Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3323 ARTÍCULOS , VIENDO DEL 2446 AL 2460

Real-time functional magnetic resonance imaging neurofeedback for treatment of Parkinson's disease

Subramanian L, Hindle JV, Johnston S, Roberts MV, Husain M, Goebel R, Linden D.

J Neurosci. 2011 Nov 9;31(45):16309-17. doi: 10.1523/JNEUROSCI.3498-11.2011.

Is neurodegenerative disease a long-latency response to early-life genotoxin exposure?

Kisby GE, Spencer PS.

Int J Environ Res Public Health. 2011 Oct;8(10):3889-921. doi: 10.3390/ijerph8103889. Epub 2011 Sep 29.

Characteristic of cognitive decline in Parkinson's disease: a 1-year follow-up

McKinlay A, Grace RC.

Appl Neuropsychol. 2011 Oct;18(4):269-77. doi: 10.1080/09084282.2011.595453.

L-Dopa prodrugs: an overview of trends for improving Parkinson's disease treatment

Di Stefano A, Sozio P, Cerasa LS, Iannitelli A.

Curr Pharm Des. 2011;17(32):3482-93. doi: 10.2174/138161211798194495.

Modelling the cost effectiveness of treatments for Parkinson's disease: a methodological review

Dams J, Bornschein B, Reese JP, Conrads-Frank A, Oertel WH, Siebert U, Dodel R.

Pharmacoeconomics. 2011 Dec;29(12):1025-49. doi: 10.2165/11587110-000000000-00000.

Leucine-rich repeat kinase 2 (LRRK2) cellular biology: a review of recent advances in identifying physiological substrates and cellular functions

Drolet RE, Sanders JM, Kern JT.

J Neurogenet. 2011 Dec;25(4):140-51. doi: 10.3109/01677063.2011.627072. Epub 2011 Nov 11.

Autophagy: renovation of cells and tissues

Mizushima N, Komatsu M.

Cell. 2011 Nov 11;147(4):728-41. doi: 10.1016/j.cell.2011.10.026.

Structural brain abnormalities in patients with Parkinson disease: a comparative voxel-based analysis using T1-weighted MR imaging and magnetization transfer imaging

Morgen K, Sammer G, Weber L, Aslan B, Müller C, Bachmann GF, Sandmann D, Oechsner M, Vaitl D, Kaps M, Reuter I.

AJNR Am J Neuroradiol. 2011 Dec;32(11):2080-6. doi: 10.3174/ajnr.A2837. Epub 2011 Nov 11.

PSP as distinguished from CBD, MSA-P and PD by clinical and imaging differences at an early stage

Kurata T, Kametaka S, Ohta Y, Morimoto N, Deguchi S, Deguchi K, Ikeda Y, Takao Y, Ohta T, Manabe Y, Sato S, Abe K.

Intern Med. 2011;50(22):2775-81. doi: 10.2169/internalmedicine.50.5954. Epub 2011 Nov 15.

Neuropsychiatric profiles in dementia

Johnson DK, Watts AS, Chapin BA, Anderson R, Burns JM.

Alzheimer Dis Assoc Disord. 2011 Oct-Dec;25(4):326-32. doi: 10.1097/WAD.0b013e31820d89b6.

Role of FK506 binding proteins in neurodegenerative disorders

Chattopadhaya S, Harikishore A, Yoon HS.

Curr Med Chem. 2011;18(35):5380-97. doi: 10.2174/092986711798194441.

Immunophilin dysfunction and neuropathology

Park HJ, Rosado JA, Redondo PC, Cho YS.

Curr Med Chem. 2011;18(35):5398-407. doi: 10.2174/092986711798194360.

Efficacy of a vibrotactile neurofeedback training in stance and gait conditions for the treatment of balance deficits: a double-blind, placebo-controlled multicenter study

Basta D, Rossi-Izquierdo M, Soto-Varela A, Greters ME, Bittar RS, Steinhagen-Thiessen E, Eckardt R, Harada T, Goto F, Ogawa K, Ernst A.

Otol Neurotol. 2011 Dec;32(9):1492-9. doi: 10.1097/MAO.0b013e31823827ec.

[Long-term care of Parkinson patients with deep brain stimulation]

Allert N, Barbe MT, Timmermann L, Coenen VA.

Fortschr Neurol Psychiatr. 2011 Dec;79(12):696-702. doi: 10.1055/s-0031-1281785. Epub 2011 Nov 16.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias